Peter de Blank at Cincinnati Children's Hospital Medical Center - Research Interests, Publications & Academic Profile

Peter de Blank

Associate Professor

Cincinnati Children's Hospital Medical Center

United States

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Nigerian students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Medical Imaging

40%

Pediatric Nutrition

40%

Brain Tumor

80%

Pediatric Oncology

60%

Pediatric

50%

Cancer Therapy

40%

Pediatric Neurosurgery

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Use of a Novel Radiographic Biomarker to Characterize Low Grade Glioma and Treatment Effect in Adolescent and Young Adults

Open Date: 2015-03-01

Close Date: 2016-03-01

Grant: Close

Imaging biomarkers of neurofibromatosis type 1-associated optic pathway gliomas

Open Date: 2014-07-01

Close Date: 2020-07-01

Grant: Close

Radiographic Biomarkers for Residual Disease in Pediatric Brain Tumors

Open Date: 2014-07-01

Close Date: 2017-06-30

Grant: Close

Radiographic biomarkers and functional outcomes of vision in optic pathway gliomas

Open Date: 2013-11-01

Close Date: 2019-06-01

Articles18

A Radiomic Approach for Evaluating Intra-Subgroup Heterogeneity in SHH and Group 4 Pediatric Medulloblastoma: A Preliminary Multi-Institutional Study

Article Link

Year:

2024

Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group

Article Link

Year:

2024

Temporal changes in treatment and late mortality and morbidity in adult survivors of childhood glioma: a report from the Childhood Cancer Survivor Study

Article Link

Year:

2024

Opportunities and Advances in Radiomics and Radiogenomics for Pediatric Medulloblastoma Tumors

Article Link

Year:

2023

Evaluating Focal Areas of Signal Intensity (FASI) in Children with Neurofibromatosis Type-1 (NF1) Treated with Selumetinib on Pediatric Brain Tumor Consortium (PBTC)-029B

Article Link

Year:

2023

A new era for myelin research in <scp>N</scp>eurofibromatosis type 1

Article Link

Year:

2023

Clinical trials: A plea to cooperative groups, consortia, pharmaceutical companies, and lead investigators for reasonable imaging protocols

Article Link

Year:

2023

An unusual presentation of bilateral optic pathway glioma in Crouzon Syndrome

Article Link

Year:

2023

Shedding New Light: Novel Therapies for Common Disorders for Children with NF1

Article Link

Year:

2023

Evolving therapies, neurocognitive outcomes, and functional independence in adult survivors of childhood glioma

Article Link

Year:

2023

Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1.

Article Link

Year:

2021

Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor.

Article Link

Year:

2021

Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers.

Article Link

Year:

2021

Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas.

Article Link

Year:

2020

A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).

Article Link

Year:

2020

Effect of age and neurofibromatosis type 1 status on white matter integrity in the optic radiations.

Article Link

Year:

2020

Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study.

Article Link

Year:

2020

Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.

Article Link

Year:

2020

Collaborators4

Robin Norris

Associate Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

Daniel Bowers

University of Texas Southwestern Department of Pediatrics

UNITED STATES

Alexander J. Towbin

UNITED STATES

Alejandro López‐Juárez

UNITED STATES

How do Nigerian students reach out?

Meet Kite AI